Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

Presentation THT 2025

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Presenter: Jacob Abraham

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Presenter: Katherine Wood

February 12, 2025

Presentation THT Abstracts 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT Abstracts 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

February 11, 2025

Presentation THT Abstracts 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Impella 5.5: A GameChanger for Cardiogenic Shock

Presenter: Jerome Crowley

February 11, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Presentation THT Abstracts 2024

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Presenter: Ameesh Isath

March 04, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2023

Shelley Wood

July 03, 2023

News Daily News

Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks

Caitlin E. Cox

June 05, 2023

Advertisement

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Impella 5.5: A GameChanger for Cardiogenic Shock

January 2025 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for June 2024

TCTMD’s Top 10 Most Popular Stories for March 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

TCTMD’s Top 10 Most Popular Stories for June 2023

Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content